# Long Covid study: The Indian Council of Medical Research (ICMR) is funding a study to determine whether a drug named colchicine can be used to treat long-Covid symptoms.
# More on long-covid, this from China: Two years after the outbreak of Covid, about half of the patients who were hospitalised, continue to have at least one symptom, says a study touted to be the longest follow-up study till date and published in The Lancet Respiratory Medicine.
# Daily tally: India reported 2,827 new cases of Covid-19 and 24 deaths in the last 24 hours.
# After Covid, geo-political challenges worry corporates: With Covid-19 becoming more “manageable” and expected to come in waves, drug-maker Cipla sees uncertainty now coming from geopolitical challenges in different parts of the world.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.